ARC Fertility wins a Bronze Digital Health Award for Connected Digital Health Telehealth and Remote Patient Monitoring, recognizing leadership in digital fertility care.
Employer
read more
ARC Fertility Highlights Landmark Global Studies Published in The Lancet Calling for National Action on Endometriosis
CUPERTINO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of...
Genetic Testing During IVF Can Improve Pregnancy Outcomes, Deserves Inclusion in Family-Forming Strategy
Preimplantation Genetic Testing for Aneuploidy (PGT-A) helps identify chromosomally normal embryos during IVF. In selected patients, generally those who are older with a higher probability of abnormal chromosomes and who have several or more embryos, this can improve the chance of pregnancy with the first and earlier embryo transfers. Miscarriage rates can also be reduced for that transfer. For employers, offering access to PGT-A within fertility benefits can support cost-effective, evidence-based care and demonstrate a commitment to inclusivity, health equity, and employee well-being.





